Point-Of-Care Diagnostics and Testing Market – Industry Insights and Overview to 2018

In this report, the global Point-Of-Care diagnostics market has been segmented on the basis of category (infectious diseases testing kits, glucose monitoring kits, cardiac markers, pregnancy and fertility testing kits, and others) and end users (patient professional monitoring kits and patient self-monitoring kits). The glucose monitoring kits market held the largest share—53.7%—of the global Point-Of-Care diagnostics market in 2013, followed by the infectious diseases testing kits market. Factors such as rising global prevalence of diabetes, technological advancements in self-monitoring of blood glucose, and the growing patient awareness toward POC testing are stimulating the growth of the glucose monitoring kits market.

Global Point-Of-Care diagnostics market excluding the blood glucose monitoring kits market was dominated by Roche (Switzerland), Alere Inc. (U.S.), Siemens AG (Germany), and Beckman Coulter, Inc. (U.S.), which together accounted for ~72% of the market. As of 2012, the global blood glucose monitoring kits market was dominated by Roche Diagnostics Limited, Johnson & Johnson (J&J), Bayer AG, and Abbott Laboratories, Inc.

Complete research of 191 market data tables & 87 figures spread through 320 pages and in-depth TOC on "Point-Of-Care Diagnostics / Testing Market”

The global Point-Of-Care diagnostics market is highly competitive with a large number of global as well as local market players. As of 2012, The fastest-growing segment—cardiac-markers market—is projected to grow at a CAGR of 15.3% from 2013 to 2018. This growth is mainly attributed to the increasing number of cardiac patients and the demand of immediate diagnosis of the diseases.

These companies together accounted for a share of ~84% of the global blood glucose monitoring kits market. New product launches and partnerships/agreements/collaborations/joint ventures are the major strategies adopted by most market players to achieve growth in the POC diagnostics market. The global POC diagnostics market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil.

Click here for more discount on this research at http://www.reportsnreports.com/contacts/discount.aspx?name=278283 .

Geographically, North America commands the largest share of the global Point-Of-Care diagnostics market in 2013, followed by Europe. A number of factors such as increase in waiver of CLIA for certain point of care diagnostic tests, fostering FDA approvals for various immunoassay techniques, easy access to POC tests through diagnostic service providers, and presence of major leading companies are driving the growth of the POC diagnostics market in North America.

However, the economic slowdown and unfavorable reimbursement scenario for tests due to government budget constraints the growth of the Point-Of-Care diagnostics market in this region. The Asia-Pacific region is poised to grow at the highest CAGR in the next five years. Factors such as huge patient population base, large number of R&D activities, and growing focus of both international and domestic players on the Asia-Pacific POC diagnostics market are propelling the growth of the POC diagnostic market in the Asia-Pacific region.

Single user license, get sample copy of “Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018” research report can be requested at http://www.reportsnreports.com/contacts/requestsample.aspx?name=278283 .

Factors such as rising prevalence of lifestyle and infectious diseases, increasing usage of home-based POC devices, technological advancements, and decreasing number of technicians in the central labs are propelling the growth of the Point-Of-Care diagnostics market. However, factors such as lack of alignment with definitive central lab methods, reluctance to change existing treatment practices, and the recall of leading glucose monitoring devices are restraining the growth of this market.

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact:Priyank TiwariUNIT no 802, Tower no. 7, SEZMagarpatta city, HadapsarPune - 411013Maharashtra, India.Tel:  +1-888-391-5441sales@reportsandreports.com